2020
DOI: 10.1093/mmy/myz132
|View full text |Cite
|
Sign up to set email alerts
|

Pyrifenox, an ergosterol inhibitor, differentially affects Cryptococcus neoformans and Cryptococcus gattii

Abstract: Cryptococcosis is a life-threatening fungal infection. New therapeutic approaches are necessary to combat cryptococcosis, as the currently available therapeutic protocols are expensive and generally result in deleterious side effects. Pyrifenox is an antifungal compound that affects phytopathogens by inhibiting the biosynthesis of ergosterol. In this study, we investigated the effects of pyrifenox on Cryptococcus neoformans and Cryptococcus gattii growth, capsule architecture and export of the major capsule co… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
2
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
2
2

Relationship

2
2

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 40 publications
2
2
0
Order By: Relevance
“…AMB, an antifungal that directly disrupts the plasma membrane through sequestration of ergosterol (46), was significantly more potent with increases in the pH of the growth environment. Similarly, fluconazole and pyrifenox, drugs that inhibit the ergosterol biosynthesis pathway (47,69), were also more effective at alkaline pH. These results reflect similar findings in Aspergillus species treated with itraconazole and AMB (48).…”
Section: Discussionsupporting
confidence: 77%
“…AMB, an antifungal that directly disrupts the plasma membrane through sequestration of ergosterol (46), was significantly more potent with increases in the pH of the growth environment. Similarly, fluconazole and pyrifenox, drugs that inhibit the ergosterol biosynthesis pathway (47,69), were also more effective at alkaline pH. These results reflect similar findings in Aspergillus species treated with itraconazole and AMB (48).…”
Section: Discussionsupporting
confidence: 77%
“…AMB, an antifungal that directly disrupts the plasma membrane through sequestration of ergosterol (41), was significantly more potent with increases in the pH of the growth environment. Similarly, fluconazole and pyrifenox, drugs that inhibit the ergosterol biosynthesis pathway (42, 64), were also more effective at alkaline pH. These results reflect similar findings in Aspergillus species treated with itraconazole and AMB (43).…”
Section: Resultssupporting
confidence: 73%
“…The significant increase in AMB activity against this mutant strain with reduced ergosterol content is consistent with our model that disruption in fungal sterols leads to pH-sensitivity. Furthermore, in a drug disc diffusion assay using Pyrifenox, a drug used to treat phytopathogens through inhibition of ergosterol biosynthesis (42), there was a significantly greater zone of clearance and inhibition of growth of wildtype C. neoformans cells when grown on media buffered to pH 8 compared to pH 5.5 (Fig 6A).…”
Section: Resultsmentioning
confidence: 99%
“…The cytotoxicity of fenbendazole to macrophages was determined using the Cytotox 96 ® non-radioactive cytotoxicity assay kit (Promega, catalog number G1780), following the manufacturer’s recommendations. As recently described by our group (43), macrophages were used for cell viability assays due to their fundamental roles in the control and/or dissemination of cryptococci (27). RAW 264.7 macrophages (10 5 cells/well in DMEM medium supplemented with 10% FBS were treated with 0.006 to 5.98 μg/ml fenbenzaole, alone or in combination with 0.06 μg/ml amphotericin B for 24 h at 37 °C in DMEM supplemented with 10% FBS.…”
Section: Methodsmentioning
confidence: 99%